Healthcare -
Biotechnology - NASDAQ - US
$ 40.61
0.794 %
$ 2.63 B
Market Cap
-17.35
P/E
KYMR - CHANGE IN WORKING CAPITAL
Change in Working Capital KYMR - Kymera Therapeutics, Inc.
2.68 M
LAST VALUE
42.94%
2 YEAR CAGR
3.05%
5 YEAR CAGR
0.00%
10 YEAR CAGR